1. Home
  2. GKOS vs SCI Comparison

GKOS vs SCI Comparison

Compare GKOS & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$177.33

Market Cap

10.9B

Sector

Health Care

ML Signal

N/A

Logo Service Corporation International

SCI

Service Corporation International

N/A

Current Price

$82.04

Market Cap

11.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
SCI
Founded
1998
1962
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
GKOS
SCI
Price
$177.33
$82.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$126.92
$98.00
AVG Volume (30 Days)
580.7K
662.2K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
N/A
1.57%
EPS Growth
N/A
7.65
EPS
N/A
1.87
Revenue
$507,442,000.00
$4,309,234,000.00
Revenue This Year
$23.32
$4.03
Revenue Next Year
$27.43
$3.73
P/E Ratio
N/A
$44.25
Revenue Growth
32.33
2.93
52 Week Low
$73.16
$68.41
52 Week High
$191.62
$90.99

Technical Indicators

Market Signals
Indicator
GKOS
SCI
Relative Strength Index (RSI) 55.85 50.40
Support Level $175.04 $82.33
Resistance Level $184.00 $83.37
Average True Range (ATR) 5.63 1.49
MACD -1.97 -0.43
Stochastic Oscillator 30.42 36.99

Price Performance

Historical Comparison
GKOS
SCI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, it provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. The company derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: